SEC Filing Summary: Prana Biotechnology Limited
Business Context and Reporting Period
This Form 6-K was filed by Prana Biotechnology Limited, a foreign private issuer based in South Melbourne, Australia, for the month of May 2008. The filing date is May 28, 2008. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notice of a change in substantial interests and does not contain financial statements or performance metrics.
Material Changes
The primary item disclosed is a "Notice of Change of Substantial Interests to Shareholder." The filing does not specify the identity of the shareholder, the nature of the change, or the percentage of ownership involved.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. No operational updates or forward-looking statements are included in this specific document.
Key Facts for Investor Verification
- Verify the identity of the shareholder whose substantial interest changed.
- Determine the specific nature of the change (e.g., acquisition, disposal) and the resulting ownership percentage.
- Confirm if this change triggers any additional disclosure requirements under Australian or US regulations.
- Note that the company name in the metadata (Altery Therapeutics Ltd) differs from the registrant name in the filing (Prana Biotechnology Limited); verify the correct entity.